Literature DB >> 25333865

Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.

Gayatri Mukherjee1, Rodolfo J Chaparro, Jennifer Schloss, Carla Smith, Christopher D Bando, Teresa P DiLorenzo.   

Abstract

Type 1 diabetes is characterized by T-cell-mediated destruction of the insulin-producing β cells in pancreatic islets. A number of islet antigens recognized by CD8 T cells that contribute to disease pathogenesis in non-obese diabetic (NOD) mice have been identified; however, the antigenic specificities of the majority of the islet-infiltrating cells have yet to be determined. The primary goal of the current study was to identify candidate antigens based on the level and specificity of expression of their genes in mouse islets and in the mouse β cell line MIN6. Peptides derived from the candidates were selected based on their predicted ability to bind H-2K(d) and were examined for recognition by islet-infiltrating T cells from NOD mice. Several proteins, including those encoded by Abcc8, Atp2a2, Pcsk2, Peg3 and Scg2, were validated as antigens in this way. Interestingly, islet-infiltrating T cells were also found to recognize peptides derived from proglucagon, whose expression in pancreatic islets is associated with α cells, which are not usually implicated in type 1 diabetes pathogenesis. However, type 1 diabetes patients have been reported to have serum autoantibodies to glucagon, and NOD mouse studies have shown a decrease in α cell mass during disease pathogenesis. Our finding of islet-infiltrating glucagon-specific T cells is consistent with these reports and suggests the possibility of α cell involvement in development and progression of disease.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  NOD mice; autoantigens; glucagon; type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25333865      PMCID: PMC4368169          DOI: 10.1111/imm.12415

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  66 in total

1.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

2.  Glucagon antibodies after long-term insulin treatment in a diabetic child.

Authors:  M Stahl; P W Nars; G Herz; J B Baumann; J Girard
Journal:  Horm Metab Res       Date:  1972-05       Impact factor: 2.936

3.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.

Authors:  Bingye Han; Pau Serra; Abdelaziz Amrani; Jun Yamanouchi; Athanasius F M Marée; Leah Edelstein-Keshet; Pere Santamaria
Journal:  Nat Med       Date:  2005-05-22       Impact factor: 53.440

5.  Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration.

Authors:  German Kilimnik; Abraham Kim; Donald F Steiner; Theodore C Friedman; Manami Hara
Journal:  Islets       Date:  2010 May-Jun       Impact factor: 2.694

6.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

7.  Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes.

Authors:  Constadina Panagiotopoulos; Huilian Qin; Rusung Tan; C Bruce Verchere
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

8.  Single pancreatic beta cells co-express multiple islet hormone genes in mice.

Authors:  H Katsuta; T Akashi; R Katsuta; M Nagaya; D Kim; Y Arinobu; M Hara; S Bonner-Weir; A J Sharma; K Akashi; G C Weir
Journal:  Diabetologia       Date:  2009-10-23       Impact factor: 10.122

9.  Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice.

Authors:  Todd Pearson; Thomas G Markees; David V Serreze; Melissa A Pierce; Michele P Marron; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  3 in total

1.  Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.

Authors:  E Nikoopour; O Krougly; E Lee-Chan; S M Haeryfar; B Singh
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

2.  Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.

Authors:  John Sidney; Jennifer Schloss; Carrie Moore; Mikaela Lindvall; Amanda Wriston; Donald F Hunt; Jeffrey Shabanowitz; Teresa P DiLorenzo; Alessandro Sette
Journal:  Immunogenetics       Date:  2016-01-11       Impact factor: 3.330

Review 3.  T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.

Authors:  Adam L Burrack; Tijana Martinov; Brian T Fife
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-05       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.